Clinical Trials Sponsored by Merit

Total 70 results

Merit University

Not yet recruiting

Shock Wave Therapy Versus Mechanical Traction on Mechanical Low Back Pain

Mechanical Low Back Pain

Egypt
Merit University

Completed

Effect of Aerobics and Balancing Exercises on Anxiety and Dizziness in Patients With COVID-19

Corona Virus Infection

Egypt
Merit University

Not yet recruiting

Effect of Aquatic Exercise and Traditional Physical Therapy on Gout in Hypertensive Menopausal Women With Hyperuricemia

Gout
Merit Medical Systems, Inc.

Recruiting

US Post-Market Surveillance Study of the Surfacer System

Venous Disease

United States
Merit Medical Systems, Inc.

Active, not recruiting

The Merit WRAPSODY AV Access Efficacy Study (WAVE) (WAVE)

Venous Stenosis | Venous Occlusion

United States, United Kingdom, Canada, Brazil
Merit Medical Systems, Inc.

Withdrawn

The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease

Peripheral Arterial Disease | Iliac Artery Occlusion | Iliac Artery Disease | Stenosis of Artery
Merit Medical Systems, Inc.

Completed

Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter (MCENPS)

Pain; Dialysis Catheter

United States
Merit Medical Systems, Inc.

Recruiting

GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)

Knee Osteoarthritis

Canada, United States, Brazil, United Kingdom
Mohammed samir

Not yet recruiting

Graded Motor Imagery Training Paradigm on Shoulder Pain

Stroke, Complication

Egypt
Merit Medical Systems, Inc.

Recruiting

EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging

Hemorrhage | Bleeding Hemorrhage

France, Australia
Merit Medical Systems, Inc.

Recruiting

Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)

Venous Stenosis | Venous Occlusion

Israel, Netherlands, Australia, United Kingdom, Brazil, Germany, New Zealand, Portugal, Greece
Merit Medical Systems, Inc.

Terminated

HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer (HiQuality)

Hepatocellular Carcinoma

United States, France, Belgium, Greece, Italy
Merit Medical Systems, Inc.

Terminated

Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Merit Medical Systems, Inc.

Not yet recruiting

Bearing nsPVA Embolization for Uterine Artery Embolization

Uterine Fibroid
Merit Medical Systems, Inc.

Recruiting

Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc )

Breast Cancer

Canada
Merit Medical Systems, Inc.

Completed

Surfacer System to Facilitate Access in Venous Occlusions (SAVE)

Chronic Venous Thrombosis | Venous Thrombosis Upper Extremity | Venous Thrombosis Upper Extremity Superficial Veins

Austria, Germany, Italy
Merit Medical Systems, Inc.

Completed

Embosphere® PROstate Post Market Study (PROstate)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States, United Kingdom, Italy, France
Merit Medical Systems, Inc.

Completed

HepaSphere™ Microspheres Prospective Registry (mCRC)

Metastatic Colorectal Cancer

France, Greece
Merit Medical Systems, Inc.

Completed

The Merit WRAPSODY™ Endovascular Stent Graft

Venous Stenosis | Venous Occlusion

United Kingdom, Greece
Merit Medical Systems, Inc.

Completed

HeRO Vascular Access Device Post Market Procedural Survey Protocol (PPS)

End Stage Renal Disease
MimiVax, LLC
Translational Drug Development; Merit

Active, not recruiting

SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) (SURVIVE)

Newly Diagnosed Glioblastoma

United States
Merit Medical Systems, Inc.
DFINE Inc.

Terminated

Evaluation of t-RFA and RF-TVA Prior to/Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s) (STARRT)

Metastatic Lesions in Vertebral Bodies

United States
Merit Medical Systems, Inc.
ClinLogix. LLC

Withdrawn

The Merit WRAPSODY Central Feasibility Study (WAVE Central)

Venous Stenosis | Venous Occlusion
Merit Medical Systems, Inc.
DFINE Inc.

Terminated

The STAR™ Tumor Ablation Registry

Metastatic Lesions in Vertebral Bodies

United States
Merit Medical Systems, Inc.
CryoLife, Inc.

Completed

HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis

End Stage Renal Disease (ESRD)

United States
DFINE Inc.

Withdrawn

Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma (MM)

Multiple Myeloma | Compression Fracture of Vertebral Column
DFINE Inc.

Withdrawn

The PRIORi-T Trial--Prospective Randomized Investigation of Radiofrequency Targeted Vertebral Augmentation (PRIORi-T)

Painful Osteoporotic Vertebral Compression Fractures (VCF)

United States
DFINE Inc.

Completed

The STAR Prospective Clinical Series (PCS)

Metastasis to Vertebral Column

United States
DFINE Inc.

Terminated

Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors (EU-STAR)

Metastatic Lesions in Vertebral Bodies

Germany, Italy, France
Merit Medical Systems, Inc.
CryoLife, Inc.

Completed

Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study

Renal Failure Chronic Requiring Hemodialysis

United States
Merit Medical Systems, Inc.
CryoLife, Inc.

Withdrawn

Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis

End Stage Renal Failure on Dialysis

United States
Merit Medical Systems, Inc.
Meditrial Europe Ltd.

Completed

Evaluation of the Surfacer System Approach to Central Venous Access (SAVEUS)

Venous Occlusion

United States
KA Medical, LLC
Merit Medical Systems, Inc.

Active, not recruiting

Micro Plug Set - Post Market Clinical Follow-up (PMCF) Plan

Bleeding | Trauma Injury

Germany
Merit E. Cudkowicz, MD
Massachusetts General Hospital

Recruiting

HEALEY ALS Platform Trial - Master Protocol

Amyotrophic Lateral Sclerosis

United States
Mervit Sersy

Recruiting

Effectiveness of Three Steps Hysteroscopic Repair of Post Caesarean Isthmocele in Patients With Post Menstrual Spotting

Abnormal Uterine Bleeding

Egypt
Yonsei University
Severance Hospital; Merit Medical Systems, Inc.

Active, not recruiting

Feasibility of PCI Using a 7-Fr Thin-Wall Sheath Via the DRA (SEVEN-BOX)

Coronary Artery Disease | Distal Radial Artery | Complex Intervention

Korea, Republic of
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
Meril Life Sciences Pvt. Ltd.

Recruiting

LANDMARK Trial: a Randomised Controlled Trial of Myval THV (LANDMARK)

Aortic Valve Stenosis

Sweden, Hungary, France, Belarus, Croatia, Germany, Netherlands, New Zealand, Poland, Portugal, Slovakia, Slovenia, Spain, Italy, Brazil, Estonia, Greece
Meril Life Sciences Pvt. Ltd.

Unknown

A Prospective, Single-arm, Multi-centre, Observational, Real World Registry (Morpheus)

Angina Pectoris

Jordan, Hungary, Malaysia, Netherlands
Meril Life Sciences Pvt. Ltd.

Completed

An Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study. (meriT-2)

Coronary Artery Disease

India
Mert Özcan

Completed

Efficacy of Peroperative Suction Drain Usage in Arthroscopic Knee Surgery

Chondropathy | Knee Effusion | Knee Hemarthrosis
Meril Life Sciences Pvt. Ltd.

Recruiting

Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.

Aortic Valve Stenosis

Slovenia, Spain, Turkey, Italy, Netherlands, Estonia, Poland
Meril Life Sciences Pvt. Ltd.

Unknown

Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. (Morph RCT-1)

Coronary Artery Disease
Meril Life Sciences Pvt. Ltd.

Unknown

Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System (MeRes-1Extend)

Coronary Artery Disease

Malaysia, Brazil, Indonesia, Macedonia, The Former Yugoslav Republic of
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Freedom® Total Knee System for Treatment of Osteoarthritis, Rheumatoid Arthritis or Post-traumatic Arthritis (Freedom®450)

Rheumatoid Arthritis | Knee Osteoarthritis | Post-traumatic Osteoarthritis
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. (MeReS100-China)

Coronary Artery Disease
Meril Life Sciences Pvt. Ltd.

Unknown

BioMime Vs. Xience Randomised Control Clinical Study (meriT-V)

Coronary Artery Disease

United Kingdom, Brazil, Spain, Macedonia, The Former Yugoslav Republic of, Belgium, Czechia, Latvia, Netherlands, Poland
Washington University School of Medicine
Merit Medical Systems, Inc.

Completed

Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection System

Malignant Pleural Effusion

United States
Merit E. Cudkowicz, MD
Prilenia Therapeutics

Completed

HEALEY ALS Platform Trial - Regimen D Pridopidine

Amyotrophic Lateral Sclerosis

United States
Merit E. Cudkowicz, MD
Ra Pharmaceuticals

Completed

HEALEY ALS Platform Trial - Regimen A Zilucoplan

Amyotrophic Lateral Sclerosis

United States

Clinical Trials Sponsored by Merit

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations